These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells. Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190 [TBL] [Abstract][Full Text] [Related]
5. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition. Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566 [TBL] [Abstract][Full Text] [Related]
6. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine. Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724 [TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689 [TBL] [Abstract][Full Text] [Related]
8. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft. Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845 [TBL] [Abstract][Full Text] [Related]
9. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597 [TBL] [Abstract][Full Text] [Related]
10. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene. Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma. Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211 [TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice. NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408 [TBL] [Abstract][Full Text] [Related]
13. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383 [TBL] [Abstract][Full Text] [Related]
15. Local bystander effect induces dormancy in human medullary thyroid carcinoma model in vivo. Kucerova L; Feketeova L; Matuskova M; Kozovska Z; Janega P; Babal P; Poturnajova M Cancer Lett; 2013 Jul; 335(2):299-305. PubMed ID: 23485727 [TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models. Park GT; Kim SU; Choi KC Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205 [TBL] [Abstract][Full Text] [Related]
17. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Porosnicu M; Mian A; Barber GN Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Yi C; Huang Y; Guo ZY; Wang SR Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785 [TBL] [Abstract][Full Text] [Related]
19. 3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment. Bohovic R; Demkova L; Cihova M; Skolekova S; Durinikova E; Toro L; Tyciakova S; Kozovska Z; Matuskova M; Kucerova L Neoplasma; 2015; 62(4):521-30. PubMed ID: 25997965 [TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]